CLINICAL ROLE -
Alexandra S. Wolff, PharmD, BCOP, comments on her experience with CPX-351 in clinical practice and the potential to combine CPX-351 with targeted agents for AML.
Homocysteine Concentration Levels May Predict Risk and Severity of Obstructive Sleep Apnea
Pharmacy Focus Oncology: Advancements in Hematology and Breast Cancer - ASH and SABCS 2023 Recap
The Evolving Treatment Landscape of Multiple Myeloma: GPRC5D-Targeted CAR T-Cell Therapy
Pharmacy Focus: Oncology Edition - Experts See Promising Future for the Treatment of Acute Lymphoblastic Leukemia
Navigating the Rapid Expansion of Cellular Therapies: Challenges and Opportunities for Community and Academic Collaboration
FDA Approves Epcoritamab for Treatment of Relapsed, Refractory Follicular Lymphoma